mTOR inhibitors: all 1,276 studies that test it
Page 10 of 13. Open to participants first (126), then studies with results posted, then the rest; newest registration first within each.
- Efficacy of Sirolimus In Liver Transplantation for Hepatocellular Carcinoma (HCC)CompletedNCT01374750Phase 2
- A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.CompletedNCT01363752Phase 4
- Efficacy and Safety of Induction Strategies Combined With Low Tacrolimus Exposure in Kidney Transplant Recipients Receiving Everolimus or Sodium MycophenolateCompletedNCT01354301Phase 4
- BIBF 1120 and RAD001 in Solid Tumors - Phase ICompletedNCT01349296Phase 1
- Study of RAD001 for Treatment of NF2-related Vestibular SchwannomaTerminatedNCT01345136Phase 2
- Temsirolimus + Sorafenib in Advanced Hepatocellular Carcinoma (HCC)WithdrawnNCT01335074Phase 1/2
- Everolimus, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Untreated Diffuse Large B-Cell LymphomaCompletedNCT01334502Phase 1
- Everolimus, Carboplatin, and Paclitaxel in Locally Advanced Head and Neck Cancer That Cannot Be Removed by SurgeryCompletedNCT01333085Phase 1/2
- Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation TherapyWithdrawnNCT01332279Phase 1
- Aflac ST0901 CHOANOME - Sirolimus in Solid TumorsCompletedNCT01331135Phase 1
- Torisel in Addition to Standard Chemotherapy With Radiation for Advanced Head and Neck CancerWithdrawnNCT01326468Not applicable
- Safety and Efficacy of RAD001 in Chinese Patients With Advanced Pulmonary Neuroendocrine TumorCompletedNCT01324492Phase 1
- Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck CancerTerminatedNCT01313390Phase 1/2
- De Novo Everolimus-based Therapy for Renal Transplantation Using Rituximab InductionTerminatedNCT01312064Phase 4
- Strategies To Prevent Cardiac Allograft Vasculopathy Related Events in Heart Transplant RecipientsWithdrawnNCT01305395Not applicable
- Tamoxifen-RAD001 Versus Tamoxifen Alone in Patients With Anti-aromatase Resistant Breast Metastatic CancerCompletedNCT01298713Phase 2
- Lapatinib and RAD-001 for HER2 Positive Metastatic Breast CancerStatus unknownNCT01283789Phase 2
- Study of Pegylated Liposomal Doxorubicin and Temsirolimus in Patients With Advanced Hepatocellular CancerWithdrawnNCT01281943Phase 2
- A Study of Carboplatin, PLD and Everolimus in Certain Gynecologic CancerCompletedNCT01281514Phase 1
- Comparison of Immunosuppression on Progression of Arteriosclerosis in Renal TransplantationTerminatedNCT01276834Phase 4
- Immediate Conversion From Tacrolimus to Everolimus in Stable Maintenance Renal Transplant RecipientsWithdrawnNCT01269684Phase 4
- Open Label, Single Arm Trial to Characterize Patients With Metastatic RCC Treated With Everolimus After Failure of the First VEGF-targeted Therapy (MARC-2)CompletedNCT01266837Phase 4
- Sirolimus or Vorinostat and Hydroxychloroquine in Advanced CancerCompletedNCT01266057Phase 1
- Efficacy and Safety of Bevacizumab/Temsirolimus Combination to Treat Advanced Renal Cell CarcinomaTerminatedNCT01264341Phase 2
- Study of Everolimus and Sorafenib in Patients With Advanced Thyroid Cancer Who Progressed on Sorafenib AloneStatus unknownNCT01263951Phase 2
- Hepatocellular Carcinoma (HCC)_Torisel_CompletedNCT01251458Phase 1/2
- A Randomized, Double Blind Study Evaluating Paclitaxel With and Without RAD001 in Patients With Gastric Carcinoma After Prior ChemotherapyCompletedNCT01248403Phase 3
- Temsirolimus-RCC-imagingStatus unknownNCT01246817Phase 2
- Everolimus for Patients With Relapsed/Refractory Germ Cell CancerCompletedNCT01242631Phase 2
- Sorafenib in Combination With RAD001 in Advanced Solid Tumors Selected on Molecular TargetsSuspendedNCT01226056Phase 1/2
- Sirolimus In Autosomal Dominant Polycystic Kidney Disease And Severe Renal InsufficiencyTerminatedNCT01223755Phase 2/3
- Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START TrialActive, not recruitingNCT01217931Phase 2
- A Study of mTOR Inhibitor Everolimus (RAD001) in Association With Cisplatin and Radiotherapy for Locally Advanced Cervix CancerCompletedNCT01217177Phase 1
- Rapamycin In Angiomyolipomas In Patients With Tuberous SclerosisCompletedNCT01217125Phase 4
- Phase II Study of Everolimus in Children and Adolescents With Refractory or Relapsed Rhabdomyosarcoma and Other Soft Tissue SarcomasStatus unknownNCT01216839Phase 2
- Phase II Study of Everolimus in Children and Adolescents With Refractory or Relapsed OsteosarcomaStatus unknownNCT01216826Phase 2
- CESAR Study in Prostate Cancer With Temsirolimus Added to Standard Docetaxel Therapy (CEPTAS)CompletedNCT01206036Phase 1/2
- Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue SarcomaTerminatedNCT01204450Phase 1
- RAD001 Combined With CHOP in Newly Diagnosed Peripheral T-cell LymphomasCompletedNCT01198665Phase 1/2
- Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome ResistanceCompletedNCT01197170Phase 1
- RAD001 in Patients With Chronic Phase Chronic Myeloid Leukemia w/ Molecular Disease.WithdrawnNCT01188889Phase 1/2
- Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)CompletedNCT01183663Phase 1
- An Open, Single Centre, Randomised, Parallel Group Study to Investigate Three Different Immunosuppressive RegimensCompletedNCT01183247Phase 4
- A Phase I Study of IMC-A12 in Combination With Temsirolimus in Pediatric Patients With Recurrent or Refractory Solid TumorsWithdrawnNCT01182883Phase 1
- Gemcitabine and Split-Dose Cisplatin Plus Everolimus (RAD001) in Patients With Advanced Solid Tumor MalignanciesCompletedNCT01182168Phase 1
- Study of Everolimus in the Treatment of Advanced Malignancies in Patients With Peutz-Jeghers SyndromeWithdrawnNCT01178151Phase 2
- Safety and Tolerability Profile of RAD001 Daily in Chinese Patients With Advanced Pulmonary Neuroendocrine TumorStatus unknownNCT01175096Phase 1/2
- Temsirolimus and Vorinostat in Treating Patients With Metastatic Prostate CancerTerminatedNCT01174199Phase 1
- Efficacy Study of Temsirolimus to Treat Head and Neck CancerCompletedNCT01172769Phase 2
- Bendamustine and Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Non-Hodgkin's Lymphoma (NHL)WithdrawnNCT01170052Phase 1/2
- Study to Evaluate RAD001 in Combination With Radiotherapy in Non-small Cell Lung CancerCompletedNCT01167530Phase 1
- Multicenter Phase II Study to Evaluate the Clinical Activity and the Safety Profile of Everolimus in Marginal Zone B-cell Lymphomas (MZL)CompletedNCT01164267Phase 2
- Everolimus in Treating Patients With Locally Advanced or Metastatic Thyroid CancerCompletedNCT01164176Phase 2
- Everolimus and LongActing Octreotide Trial in Polycystic LiversCompletedNCT01157858Phase 2
- Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNCT01155258Phase 1
- Everolimus MICE-regimen in Treating Older Patients With Newly Diagnosed Acute Myeloid LeukemiaCompletedNCT01154439Phase 1
- Study of RAD001 in Adenoid Cystic CarcinomaCompletedNCT01152840Phase 2
- RAD001 in Pheochromocytoma or Nonfunctioning CarcinoidCompletedNCT01152827Phase 2
- Safety of RAD001 in Chinese Patients With Metastatic Renal Cell CancerCompletedNCT01152801Phase 1
- Dose-finding Study of CAELYXTM and RAD001 in Patients With Advanced Solid TumorsStatus unknownNCT01148628Phase 1
- Evaluating the Combination of Everolimus and Sorafenib in the Treatment of Thyroid CancerActive, not recruitingNCT01141309Phase 2
- Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid TumorsCompletedNCT01141244Phase 1
- Safety Study of the Combination of Panitumumab, Irinotecan and Everolimus in the Treatment of Advanced Colorectal CancerCompletedNCT01139138Phase 1/2
- Study of Vinblastine and Sirolimus in Children With Recurrent/Refractory Solid Tumours Including CNS TumoursCompletedNCT01135563Phase 1
- Sunitinib Plus Temsirolimus in Patients With Renal Cell Cancer (RCC)CompletedNCT01122615Phase 1
- Everolimus in Treating Patients With Progressive or Recurrent, Unresectable, or Metastatic Thyroid CancerStatus unknownNCT01118065Phase 2
- Temsirolimus in Myelodysplastic Syndrome (MDS)TerminatedNCT01111448Phase 2
- Pilot Study of Neo-Adjuvant Everolimus to Treat Advanced Renal Cell Carcinoma - Analysis of BiomarkersCompletedNCT01107509Not applicable
- A Trial of RAD001/Capecitabine in Refractory Gastric CancerCompletedNCT01099527Phase 1/2
- A Study of TS-1, Cisplatin (CDDP) and RAD001 (Everolimus)TerminatedNCT01096199Phase 1
- Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the UrotheliumCompletedNCT01090466Phase 1/2
- Everolimus in Breast Cancer Patients After Pre-operative ChemotherapyStatus unknownNCT01088893Phase 2
- Lapatinib With Sirolimus or MetforminCompletedNCT01087983Phase 1
- Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced CancerActive, not recruitingNCT01087554Phase 1
- Temsirolimus in Treating Patients With Advanced Liver Cancer and CirrhosisTerminatedNCT01079767Phase 2
- Everolimus and Capecitabine in Patients With Advanced MalignancyStatus unknownNCT01079702Phase 1/2
- Combination Anticancer Therapy of Paclitaxel and Everolimus for Relapsed or Refractory Small Cell Lung CancerCompletedNCT01079481Phase 1
- Study of Nelfinavir and Temsirolimus in Patients With Advanced CancersCompletedNCT01079286Phase 1
- Temsirolimus, Bendamustine and Rituximab for Relapsed Follicular Lymphoma or Mantle Cell LymphomaCompletedNCT01078142Phase 1/2
- Everolimus, Cetuximab and Capecitabine in Patients With Metastatic Pancreatic CancerCompletedNCT01077986Phase 1/2
- Phase I Study in RAD 001 Patients With Relapse AMLCompletedNCT01074086Phase 1
- Temsirolimus and Pazopanib in Patients With Advanced Solid TumorsCompletedNCT01072890Phase 1
- Dose Escalation Study of RAD001 in Combination w/Chemotherapy & Radiation in Patients With NSCLCTerminatedNCT01063478Phase 1
- A Trial of AMG 479, Everolimus (RAD001) and Panitumumab in Patients With Advanced Cancer - QUILT-3.007CompletedNCT01061788Phase 1
- Pre Transplant Rapamycin Treatment in Islet Transplantation AloneCompletedNCT01060605Phase 3
- RAD001 With Weekly Cisplatin and Radiation Therapy in Patients With Locally Advanced Head and Neck CancerTerminatedNCT01058408Phase 1
- Docetaxel and Sirolimus in Patients With Advanced MalignanciesCompletedNCT01054313Phase 1
- A Study of Temsirolimus Plus Capecitabine in Patients With Advanced CancerCompletedNCT01050985Phase 1
- Perifosine With Temsirolimus for Recurrent Pediatric Solid TumorsCompletedNCT01049841Phase 1
- RAD001 in Combination With Capecitabine and Oxaliplatin (XELOX) in Patients With Advanced Gastric Cancer: RAD001+XELOXCompletedNCT01049620Phase 1
- Everolimus Rescue Immunosuppression in the Treatment of Chronic Allograft Dysfunction in Renal Transplant RecipientsCompletedNCT01046045Phase 4
- Phase I Study of Daily RAD001 in Combination With Mitomycin C in Patients With Advanced Gastric Cancer or Cancer of the Esophagogastric JunctionCompletedNCT01042782Phase 1
- A Randomised Trial With Irinotecan, Cetuximab and Everolimus (ICE)Compared to Capecitabine and Oxaliplatin (CapOx) for Patients With Gemcitabin Resistant Pancreatic CancerTerminatedNCT01042028Phase 1/2
- Comparison of Tacrolimus and Myfortic Versus Tacrolimus and SirolimusWithdrawnNCT01038505Phase 4
- Effect of Rapamycin on Tolerance-related Biomarkers on Stable Liver Transplant RecipientsStatus unknownNCT01034345Phase 2
- mTor-inhibitor (EVERolimus) Based Immunosuppressive Strategies for CNI Minimisation in OLD for Old Renal TransplantationCompletedNCT01028092Phase 3
- Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed GlioblastomaCompletedNCT01019434Phase 2
- Combination of Cisplatin, Cetuximab and Temsirolimus in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckTerminatedNCT01015664Phase 1/2
- Rapamycin and Regulatory T Cells in Kidney TransplantationCompletedNCT01014234Phase 2
- Everolimus on CKD Progression in ADPKD PatientsTerminatedNCT01009957Phase 2/3